Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating activities:
Net loss	$ (67,599)	$ (136,937)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	7,063	5,077
Expensed in-process research and development		2,679
Premium amortization and discount accretion on investment securities	(460)	787
Stock-based compensation	64,447	40,477
Non-cash lease expense	3,593	3,806
Amortization of debt discount and issuance cost	328	320
Foreign exchange adjustment	359	265
Non-cash interest expense	(1)	48
Changes in operating assets and liabilities:
Accounts receivable	(10,459)	(2,400)
Inventory	(2,265)	(5,277)
Prepaid expenses and other assets	14,428	2,338
Accounts payable	10,732	5,762
Accrued compensation	17,789	14,993
Operating lease liabilities	(4,122)	(2,177)
Other accrued liabilities	(7,625)	(18,181)
Deferred revenue	793	7,312
Cash provided by (used in) operating activities	27,001	(81,108)
Investing activities:
Proceeds from maturity of investments	169,065	27,250
Purchases of property and equipment, net	(20,315)	(11,380)
Cash paid for acquisition of an asset	(10,495)
Cash provided by investing activities	138,255	15,870
Financing activities:
Proceeds from exercise of stock options	6,466	2,301
Cash provided by financing activities	6,466	2,301
Net change in cash, cash equivalents and restricted cash	171,722	(62,937)
Cash, cash equivalents and restricted cash, beginning of period	642,095	466,091
Cash, cash equivalents and restricted cash, end of period	813,817	403,154
Supplemental disclosure of cash flow information:
Cash paid for interest	1,179	1,124
Non-cash investing and financing activities:
Purchases of property and equipment in accounts payable and accruals	112	1,613
Acquisition of warrants	1,884
Issuance of common stock for IPR&D acquisition		14,435
Issuance of common stock for bonuses	24,071	19,771
Stock-based compensation included in capitalized software development costs	$ 505	$ 218